News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Natac organic certified
Natac is now organic certified! 
Healthcare · Agrifood · Agriculture · BioSpain · Corporate
Natac has officially announced that the Hervás manufacturing facility received its organic…
ysios pic
SpliceBio Raises EUR 50M in Oversubscribed Series A financing to Advance Protein Splicing Platform and Expand Gene Therapy Pipelin
Financing
Financing co-led by UCB Ventures and Ysios Capital with participation by New Enterprise …
oryzon
ORYZON to give updates on corporate progress in February and March
Oryzon Genomics, S.A., a public clinical-stage biopharmaceutical company leveraging epigenetics to…
oryzon
ORYZON reports results and corporate update for Q4 and year ended December 31, 2021
Oryzon Genomics, S.A., a clinical-stage biopharmaceutical company leveraging epigenetics to develop…
BCN HEALTH
BCN HEALTH strengthens its Health Economics department as a result of Therapeutic Positioning Reports
BCN HEALTH has expanded its Health Economics department following the inclusion of economic…
Euronext
Euronext launches 7th edition of its pan-European pre-IPO educational programme TechShare
foto 25 enero bcn
BCN HEALTH publishes a study evaluating the incidence, mortality and medical costs associated to melanoma in Spain
El objetivo de este estudio fue analizar las características de los pacientes con melanoma tratados…
salud mental
54% of Europeans consider their current physical health to be good or very good, as survey reveals public perceptions of health following nearly two years of the Covid 19 pandemic
Coronavirus
“Merck Survey: Europeans' perception of health two years after the start of Covid 19” carried out…
almirall pic
Almirall initiates experimental phase of Lebrikizumab trial in AD patients that have failed or are unsuitable to oral Cyclosporine
The ADvantage study, whose principal investigator and coordinator is Professor Richard Warren of…